SPY330.65-3.85 -1.15%
DIA276.52-2.38 -0.85%
IXIC10,793.28-117.00 -1.07%

H.C. Wainwright Reiterates Buy on Momenta Pharmaceuticals, Raises Price Target to $40

H.C. Wainwright reiterates Momenta Pharmaceuticals (NASDAQ:MNTA) with a Buy and raises the price target from $36 to $40.

Benzinga · 05/08/2020 13:28

H.C. Wainwright reiterates Momenta Pharmaceuticals (NASDAQ:MNTA) with a Buy and raises the price target from $36 to $40.